The drug for the treatment of a variety of malignant tumors.
Indication for doxorubicin (1) acute leukemia. Acute lymphoblastic leukemia and myeloid leukemia are valid.
(2) malignant lymphoma. For the treatment of Hodgkin's disease and non-Hodgkin's lymphoma, one of the drugs of choice, single-use efficiency was 60% – 75% and 45% – 65%, inclusive of many joint programs in the ADM.
Indication for doxorubicin (3) breast cancer . For the treatment of one of the most effective drug in breast cancer, single-use efficiency 30% – 45%.
(4) bone and soft tissue sarcoma. Doxorubicin is an effective treatment of soft tissue sarcoma of the single drug, its efficacy and dose-related. Treatment of osteosarcoma is a common and effective drugs.
Indication for doxorubicin (5) lung cancer. Of squamous cell carcinoma and small cell lung cancer is better, similar efficacy and CTX.
Indication for doxorubicin (6) other. Of bladder cancer, testicular cancer, head and neck cancer, neuroblastoma, Wilms tumor, esophageal cancer, liver cancer, stomach cancer , ovarian cancer, cervical cancer, prostate cancer is also effective in the film adenocarcinoma, brain tumors, uterine cancer, multiple myeloma have a certain effect.